241. PK/PD Studies: Saturday, 12:15 - 1:30 p.m.
Poster Session: PK/PD Studies
Gina Patel, MPharm, PhD (she/her/hers)
President and CEO
Patel Kwan Consultancy LLC
Middleton, Wisconsin, United States
Bibiana CastaƱeda-Ruiz, MD
AN2 Therapeutics
Menlo Park, California, United States
Tatsuya Yoshihara, MD, PhD
Fukuoka Mirai Hospital Clinical Reserch Center
Fukuoka, Fukuoka, Japan
Kevin M. Krause, MBA
AN2 Therapeutics, Inc.
Menlo Park, California, United States
Kevin O'Shea, BS
AN2 Therapeutics
Menlo Park, California, United States
Linda Kammerer, BS
AN2 Therapeutics
Menlo Park, California, United States
Gary Maier, PhD
Maier Metrics and Associates, LLC
Worcester, Massachusetts, United States
Jennifer Long, MSPH
AN2 Therapeutics, Inc.
Menlo Park, California, United States
Alex Smith, MS
AN2 Therapeutics
Menlo Park, California, United States
Sanjay Chanda, PhD
AN2 Therapeutics, Inc.
Menlo Park, California, United States
Stephanie Moore, BS
AN2 Therapeutics
Menlo Park, California, United States
Paul B. Eckburg, MD (he/him/his)
Chief Medical Officer
AN2 Therapeutics
Mountain View, CA, United States